Sheikh-Taha, Marwan <br/><br/>
Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience.  [electronic resource] 

 -  American journal of cardiovascular drugs : drugs, devices, and other interventions  Feb 2019 
 - 59-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-187X 
<br/><br/><label>Standard No.: </label>10.1007/s40256-018-0300-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antidotes--therapeutic use<br/>Antithrombins--therapeutic use<br/>Atrial Fibrillation--drug therapy<br/>Blood Coagulation--drug effects<br/>Dabigatran--therapeutic use<br/>Female<br/>Hemorrhage--drug therapy<br/>Hemostasis--drug effects<br/>Humans<br/>Intracranial Hemorrhages--drug therapy<br/>Male<br/>Middle Aged<br/>Thrombosis--drug therapy<br/>Treatment Outcome